|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Krieger N, Bassett MT and Gomez SL: Breast
and cervical cancer in 187 countries between 1980 and 2010. Lancet.
379:1391–1392. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rogers L, Siu SS, Luesley D, Bryant A and
Dickinson HO: Radiotherapy and chemoradiation after surgery for
early cervical cancer. Cochrane Database Syst Rev.
5:CD0075832012.PubMed/NCBI
|
|
4
|
Yuan W, Xiaoyun H, Haifeng Q, Jing L,
Weixu H, Ruofan D, Jinjin Y and Zongji S: MicroRNA-218 enhances the
radiosensitivity of human cervical cancer via promoting radiation
induced apoptosis. Int J Med Sci. 11:691–696. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Metheetrairut C and Slack FJ: MicroRNAs in
the ionizing radiation response and in radiotherapy. Curr Opin
Genet Dev. 23:12–19. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bernstein E, Caudy AA, Hammond SM and
Hannon GJ: Role for a bidentate ribonuclease in the initiation step
of RNA interference. Nature. 409:363–366. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hummel R, Hussey DJ and Haier J:
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in
different tumour types. Eur J Cancer. 46:298–311. 2010. View Article : Google Scholar
|
|
8
|
Zhang B, Wang Q and Pan X: MicroRNAs and
their regulatory roles in animals and plants. J Cell Physiol.
210:279–289. 2007. View Article : Google Scholar
|
|
9
|
Ke G, Liang L, Yang JM, Huang X, Han D,
Huang S, Zhao Y, Zha R, He X and Wu X: MiR-181a confers resistance
of cervical cancer to radiation therapy through targeting the
pro-apoptotic PRKCD gene. Oncogene. 32:3019–3027. 2013. View Article : Google Scholar
|
|
10
|
Chen HM, Hsu JH, Liou SF, Chen TJ, Chen
LY, Chiu CC and Yeh JL: Baicalein, an active component of
Scutellaria baicalensis Georgi, prevents
lysophosphatidylcholine-induced cardiac injury by reducing reactive
oxygen species production, calcium overload and apoptosis via MAPK
pathways. BMC Complement Altern Med. 14:2332014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bourton EC, Plowman PN, Smith D, Arlett CF
and Parris CN: Prolonged expression of the γ-H2AX DNA repair
biomarker correlates with excess acute and chronic toxicity from
radiotherapy treatment. Int J Cancer. 129:2928–2934. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ohba S, Mukherjee J, See WL and Pieper RO:
Mutant IDH1-driven cellular transformation increases RAD51-mediated
homologous recombination and temozolomide resistance. Cancer Res.
74:4836–4844. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Song L, Lin C, Wu Z, Gong H, Zeng Y, Wu J,
Li M and Li J: miR-18a impairs DNA damage response through
downregulation of ataxia telangiectasia mutated (ATM) kinase. PLoS
One. 6:e254542011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu CW, Dong YJ, Liang QY, He XQ, Ng SS,
Chan FK, Sung JJ and Yu J: MicroRNA-18a attenuates DNA damage
repair through suppressing the expression of ataxia telangiectasia
mutated in colorectal cancer. PLoS One. 8:e570362013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shiloh Y and Ziv Y: The ATM protein
kinase: regulating the cellular response to genotoxic stress, and
more. Nat Rev Mol Cell Biol. 14:197–210. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Borgstahl GE, Brader K, Mosel A, Liu S,
Kremmer E, Goettsch KA, Kolar C, Nasheuer HP and Oakley GG:
Interplay of DNA damage and cell cycle signaling at the level of
human replication protein A. DNA Repair (Amst). 21:12–23. 2014.
View Article : Google Scholar
|
|
17
|
Bakkenist CJ and Kastan MB: DNA damage
activates ATM through intermolecular autophosphorylation and dimer
dissociation. Nature. 421:499–506. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakano T, Kato S, Ohno T, Tsujii H, Sato
S, Fukuhisa K and Arai T: Long-term results of high-dose rate
intracavitary brachy-therapy for squamous cell carcinoma of the
uterine cervix. Cancer. 103:92–101. 2005. View Article : Google Scholar
|
|
19
|
Qi L, Xing LN, Wei X and Song SG: Effects
of VEGF suppression by small hairpin RNA interference combined with
radiotherapy on the growth of cervical cancer. Genet Mol Res.
13:5094–5106. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tao J, Wu D, Li P, Xu B, Lu Q and Zhang W:
microRNA-18a, a member of the oncogenic miR-17–92 cluster, targets
Dicer and suppresses cell proliferation in bladder cancer T24
cells. Mol Med Rep. 5:167–172. 2012.
|
|
24
|
Liu WH, Yeh SH, Lu CC, Yu SL, Chen HY, Lin
CY, Chen DS and Chen PJ: MicroRNA-18a prevents estrogen
receptor-alpha expression, promoting proliferation of
hepatocellular carcinoma cells. Gastroenterology. 136:683–693.
2009. View Article : Google Scholar
|
|
25
|
Fujiya M, Konishi H, Mohamed Kamel MK,
Ueno N, Inaba Y, Moriichi K, Tanabe H, Ikuta K, Ohtake T and Kohgo
Y: microRNA-18a induces apoptosis in colon cancer cells via the
autophagolysosomal degradation of oncogenic heterogeneous nuclear
ribonucleoprotein A1. Oncogene. 33:4847–4856. 2014. View Article : Google Scholar
|
|
26
|
Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang
J, McCarthy JB, She X, Zhang W, Ma J, et al: miR-18a promotes
malignant progression by impairing microRNA biogenesis in
nasopha-ryngeal carcinoma. Carcinogenesis. 34:415–425. 2013.
View Article : Google Scholar
|
|
27
|
Symington LS and Gautier J: Double-strand
break end resection and repair pathway choice. Annu Rev Genet.
45:247–271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Valdiglesias V, Giunta S, Fenech M, Neri M
and Bonassi S: γH2AX as a marker of DNA double strand breaks and
genomic instability in human population studies. Mutat Res.
753:24–40. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kinner A, Wu W, Staudt C and Iliakis G:
Gamma-H2AX in recognition and signaling of DNA double-strand breaks
in the context of chromatin. Nucleic Acids Res. 36:5678–5694. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hu H, Du L, Nagabayashi G, Seeger RC and
Gatti RA: ATM is downregulated by N-Myc-regulated microRNA-421.
Proc Natl Acad Sci USA. 107:1506–1511. 2010. View Article : Google Scholar
|
|
31
|
Yan D, Ng WL, Zhang X, Wang P, Zhang Z, Mo
YY, Mao H, Hao C, Olson JJ, Curran WJ, et al: Targeting DNA-PKcs
and ATM with miR-101 sensitizes tumors to radiation. PLoS One.
5:e113972010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ng WL, Yan D, Zhang X, Mo YY and Wang Y:
Over-expression of miR-100 is responsible for the low-expression of
ATM in the human glioma cell line: M059J. DNA Repair (Amst).
9:1170–1175. 2010. View Article : Google Scholar
|
|
33
|
Weidhaas JB, Babar I, Nallur SM, Trang P,
Roush S, Boehm M, Gillespie E and Slack FJ: MicroRNAs as potential
agents to alter resistance to cytotoxic anticancer therapy. Cancer
Res. 67:11111–11116. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Josson S, Sung SY, Lao K, Chung LW and
Johnstone PA: Radiation modulation of microRNA in prostate cancer
cell lines. Prostate. 68:1599–1606. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F,
Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z and Chun-Sheng
K: MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell
proliferation and radioresistance by targeting PTEN. BMC Cancer.
10:3672010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xue Q, Sun K, Deng HJ, Lei ST, Dong JQ and
Li GX: Anti-miRNA-221 sensitizes human colorectal carcinoma cells
to radiation by upregulating PTEN. World J Gastroenterol.
19:9307–9317. 2013. View Article : Google Scholar
|
|
37
|
Huang S, Li XQ, Chen X, Che SM, Chen W and
Zhang XZ: Inhibition of microRNA-21 increases radiosensitivity of
esophageal cancer cells through phosphatase and tensin homolog
deleted on chromosome 10 activation. Dis Esophagus. 26:823–831.
2013. View Article : Google Scholar
|
|
38
|
Chen G, Zhu W, Shi D, Lv L, Zhang C, Liu P
and Hu W: microRNA-181a sensitizes human malignant glioma U87MG
cells to radiation by targeting Bcl-2. Oncol Rep. 23:997–1003.
2010.PubMed/NCBI
|
|
39
|
He L, He X, Lim LP, de Stanchina E, Xuan
Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al: A microRNA
component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu Y, Liu GL, Liu SH, Wang CX, Xu YL, Ying
Y and Mao P: MicroRNA-148b enhances the radiosensitivity of
non-Hodgkin’s lymphoma cells by promoting radiation-induced
apoptosis. J Radiat Res (Tokyo). 53:516–525. 2012. View Article : Google Scholar
|
|
41
|
Arora H, Qureshi R, Jin S, Park AK and
Park WY: miR-9 and let-7g enhance the sensitivity to ionizing
radiation by suppression of NFκB1. Exp Mol Med. 43:298–304. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Babar IA, Czochor J, Steinmetz A, Weidhaas
JB, Glazer PM and Slack FJ: Inhibition of hypoxia-induced miR-155
radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther.
12:908–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang JX, Qian D, Wang FW, Liao DZ, Wei
JH, Tong ZT, Fu J, Huang XX, Liao YJ, Deng HX, et al: MicroRNA-29c
enhances the sensitivities of human nasopharyngeal carcinoma to
cisplatin-based chemotherapy and radiotherapy. Cancer Lett.
329:91–98. 2013. View Article : Google Scholar
|
